Filing search / Fate Therapeutics, Inc. / "Litigation" / Page 3

8-K

EX-99.1

8v9j7f3t0e0maouw

4 May 22

Fate Therapeutics Reports First Quarter 2022 Financial Results and Highlights Operational Progress

4:06pm

8-K

EX-99.1

u2noa

28 Feb 22

Fate Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Operational Progress

4:06pm

8-K

EX-99.1

e4jab s0ed

14 Dec 21

Other Events

5:28pm

8-K

EX-99.2

q46ri6drmopk76 4xif0

14 Dec 21

Other Events

5:28pm

8-K

EX-1.1

wrvk0afi37zlc fb40e2

4 Nov 21

Entry into a Material Definitive Agreement

4:59pm

S-3ASR

kt5fqg

4 Nov 21

Automatic shelf registration

4:56pm

S-3ASR

EX-1.2

i1991 5zhsst

4 Nov 21

Automatic shelf registration

4:56pm

8-K

EX-99.1

x6u8325hkeq6kl ioi

4 Nov 21

Fate Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Operational Progress

4:07pm

8-K

EX-99.1

w7z64pp

4 Aug 21

Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress

4:05pm

8-K

EX-99.1

9d0dmuajw6az8cfi

4 Aug 21

Fate Therapeutics Appoints Yuan Xu to its Board of Directors

9:20am

8-K

EX-99.1

s9oj 0z7m

5 May 21

Fate Therapeutics Reports First Quarter 2021 Financial Results and Highlights Operational Progress

4:01pm